Tag Archives: pfe

Tax-Inversion Rules Don’t Kill Pfizer-Allergan Hopes

Shares of drug giants Pfizer (PFE) and Allergan (AGN) were both up Friday as analysts said new U.S. Treasury guidelines on tax-inversion deals shouldn’t hinder the two companies’ possible merger. New York-based Pfizer has been in talks with Ireland-based Allergan since late last month about the possibility of a buyout that would allow Pfizer to relocate to Allergan’s lower-tax home. Wall Street generally approved of the idea, but on Thursday both

Pfizer-Allergan A Go Despite New Tax Inversion Rules?

As expected, the Treasury Department late Thursday issued tougher rules governing tax inversions, where a U.S. company buys an overseas firm and then moves its headquarters to that country to get more favorable tax treatment. It wasn’t clear immediately how the new rules might impact a possible Pfizer (PFE) acquisition of Ireland-based Allergan (AGN), a deal valued at up to $157 billion. Pfizer and Allergan shares edged higher in late trading

Pfizer, Allergan Near Deal Despite Treasury Warning

Big pharma Pfizer (PFE) was reportedly near a deal to acquire Ireland-based Allergan (AGN) on Thursday, even as the Treasury Department said it would put out new guidance to cut the economic benefits of such deals. Pfizer and Allergan confirmed rumors that they were in such talks late last month, but details such as price were left to Wall Street speculation. Late Wednesday, however, Bloomberg and Reuters both reported that the price had been set